IL74155A - Passive heterologous immunization composition containing a protein antibody derived from domesticated fowl or bovids - Google Patents

Passive heterologous immunization composition containing a protein antibody derived from domesticated fowl or bovids

Info

Publication number
IL74155A
IL74155A IL74155A IL7415585A IL74155A IL 74155 A IL74155 A IL 74155A IL 74155 A IL74155 A IL 74155A IL 7415585 A IL7415585 A IL 7415585A IL 74155 A IL74155 A IL 74155A
Authority
IL
Israel
Prior art keywords
bovids
composition containing
antibody derived
protein antibody
domesticated fowl
Prior art date
Application number
IL74155A
Other languages
English (en)
Other versions
IL74155A0 (en
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of IL74155A0 publication Critical patent/IL74155A0/xx
Publication of IL74155A publication Critical patent/IL74155A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
IL74155A 1984-02-07 1985-01-25 Passive heterologous immunization composition containing a protein antibody derived from domesticated fowl or bovids IL74155A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57780484A 1984-02-07 1984-02-07
US06/622,130 US4748018A (en) 1984-02-07 1984-06-19 Method of passive immunization of mammals using avian antibody

Publications (2)

Publication Number Publication Date
IL74155A0 IL74155A0 (en) 1985-04-30
IL74155A true IL74155A (en) 1989-06-30

Family

ID=27077340

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74155A IL74155A (en) 1984-02-07 1985-01-25 Passive heterologous immunization composition containing a protein antibody derived from domesticated fowl or bovids

Country Status (12)

Country Link
US (1) US4748018A (en, 2012)
EP (2) EP0152270B1 (en, 2012)
JP (6) JP2548115B2 (en, 2012)
AT (1) ATE135016T1 (en, 2012)
CA (3) CA1275044A (en, 2012)
DE (1) DE3504221C2 (en, 2012)
DK (2) DK166905B1 (en, 2012)
GR (1) GR850323B (en, 2012)
HK (1) HK1000183A1 (en, 2012)
IE (1) IE64365B1 (en, 2012)
IL (1) IL74155A (en, 2012)
NZ (1) NZ211030A (en, 2012)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
US5932250A (en) * 1982-06-03 1999-08-03 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5130128A (en) * 1982-06-03 1992-07-14 Stolle Research & Development Corporation Use of honey as vaccine
EP0225254B1 (en) * 1985-11-25 1994-03-16 Ghen Corporation Specific antibody-containing substance from eggs and method of production and use thereof
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
US5565550A (en) * 1987-05-04 1996-10-15 Dana Farber Cancer Institute Antibodies to ICAM-2, and fragments thereof
US5284931A (en) * 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
JP2641228B2 (ja) * 1988-01-22 1997-08-13 鐘紡株式会社 抗体およびそれを有効成分とするう蝕予防剤、並びにこれらの製造方法
US5059419A (en) * 1988-06-09 1991-10-22 Grand Laboratories, Inc. Streptococcus suis antiserum and its use in treating Streptococcus suis infections
JP2689511B2 (ja) * 1988-08-18 1997-12-10 ライオン株式会社 食 品
US6511664B1 (en) 1989-03-09 2003-01-28 Dana Farber Cancer Institute Intercellular adhesion molecule—2 and its binding ligands
US6932968B1 (en) 1989-07-26 2005-08-23 Dade Behring Marburg Gmbh Erythropoietin (EPO) peptides and antibodies directed against these
DE3924746A1 (de) * 1989-07-26 1991-01-31 Behringwerke Ag Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
US7005560B1 (en) * 1989-10-27 2006-02-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A
US5196193A (en) * 1989-10-31 1993-03-23 Ophidian Pharmaceuticals, Inc. Antivenoms and methods for making antivenoms
US5958413A (en) * 1990-11-01 1999-09-28 Celltech Limited Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
JP2553445B2 (ja) * 1992-12-17 1996-11-13 同仁医薬化工株式会社 抗体の安定化方法
WO1994027623A1 (en) * 1993-05-26 1994-12-08 Stolle Research & Development Corporation Anti-cholesterolemic egg, vaccine and method for production, and use
US6068862A (en) * 1993-06-30 2000-05-30 Taiyo Kagaku Co., Ltd. Tea-derived feed additive and animal feed containing the same
AU1518595A (en) * 1994-01-14 1995-08-01 Genentech Inc. Antagonists to insulin receptor tyrosine kinase inhibitor
DK0749321T3 (da) * 1994-02-09 2007-03-12 Epitopix Llc Aktiv immunisering under anvendelse af et sideroforreceptorprotein
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US5814316A (en) * 1994-08-05 1998-09-29 Wisconsin Alumni Research Foundation Compound to mimick a naturally occurring peptide's effect
JP3884069B2 (ja) * 1994-08-05 2007-02-21 ウィスコンシン アルムニ リサーチ ファウンデーション 給餌効率を向上させるために使用されるｃｃｋ抗体
US5939269A (en) * 1994-12-28 1999-08-17 The Regents Of The University Of California Antagonists to insulin receptor tyrosine kinase inhibitor
CA2218601A1 (en) * 1995-03-24 1996-10-03 Ophidian Pharmaceuticals, Inc. Treatment for verotoxin-producing escherichia coli
FI955389A0 (fi) * 1995-11-09 1995-11-09 Antti Sakari Aaltonen Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
US6413515B1 (en) * 1996-03-12 2002-07-02 Ovogenix Immunpharma Gmbh Avian, vitelline antibodies directed against HIV antigens
US5807551A (en) * 1996-04-01 1998-09-15 Iowa State University Research Foundation, Inc. Method to provide artificial passive immunity in birds
US5725873A (en) * 1996-07-22 1998-03-10 Wisconsin Alumni Research Foundation Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
KR20000048855A (ko) * 1996-10-02 2000-07-25 오비뮨, 인크. 닭의 난황 항체를 경구 투여하여 질병을 치료하는 방법
JP3430853B2 (ja) 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
JPH10298105A (ja) * 1997-04-23 1998-11-10 Gen Corp:Kk 腸管出血性大腸菌による感染症の予防剤および治療剤
WO1998055143A1 (en) * 1997-06-04 1998-12-10 The Arizona Board Of Regents On Behalf Of The University Of Arizona Lipid-reduced oral formulation for egg yolk-derived therapeutic protein
US6086878A (en) * 1997-08-21 2000-07-11 Dcv, Inc. Method of increasing muscle protein and reducing fat in animals
CZ287956B6 (cs) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě parvovirózy psů
US6395273B1 (en) * 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
JP2000351735A (ja) 1999-04-09 2000-12-19 Akzo Nobel Nv カンピロバクターワクチン
US7241443B1 (en) * 1999-07-15 2007-07-10 Camas Incorporated Immunogen adherence inhibitor and method of making and using same
US7238351B2 (en) * 1999-07-15 2007-07-03 Peter Nash Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
WO2001013928A1 (en) * 1999-08-24 2001-03-01 Ortho Corporation Co., Ltd. Methods of pasteurizing immune substance containing antiinflammatory factor and utilization thereof
US6706267B1 (en) 1999-09-14 2004-03-16 Arkion Life Sciences Llc Glucosamine and egg for reducing inflammation
GB0002386D0 (en) * 2000-02-02 2000-03-22 Novartis Nutrition Ag Therapeutic composition
AU2001249388A1 (en) * 2000-03-24 2001-10-08 Trouw Nutrition Usa Combination of plasma and hyperimmunized products for increased performance
DK1353689T3 (da) 2001-01-03 2006-07-31 Epitopix Llc Immuniseringspræparater og anvendelse deraf
CA2339436A1 (fr) 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
WO2002094124A2 (en) * 2001-05-18 2002-11-28 Arkion Life Sciences Method of increasing uniformity in avians
CA2392344A1 (en) * 2001-07-02 2003-01-02 Nutratech Inc. Method for removal of pathogens from a localized environment
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
WO2003061693A1 (en) * 2001-12-28 2003-07-31 Camas, Incorporated Immunogen adherence and method of making and using same
KR100489615B1 (ko) * 2002-01-30 2005-05-17 주식회사 단바이오텍 리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
MXPA04007694A (es) * 2002-02-11 2004-11-10 Arkion Life Sciences Llc Factor inhibidor de citosina purificada.
US20040005327A1 (en) * 2002-05-16 2004-01-08 Subramanian Iyer Immune T-cell stimulation
US6729265B2 (en) * 2002-06-27 2004-05-04 Arkion Life Sciences Llc Supplemented antibody feed to enter the circulating system of newborns
CN1819844B (zh) * 2003-02-19 2012-02-22 彼得·纳什 免疫原粘附抑制剂及其制备和使用方法
US9701737B2 (en) * 2003-02-19 2017-07-11 Camas, Incorporated Immunogen adherence and method of making and using same
WO2005003173A1 (en) * 2003-07-07 2005-01-13 Luiz Fernando Mesquita Process of obtaining a freeze-dried complex from mammal gland secretion
US8119147B2 (en) * 2003-09-19 2012-02-21 Epitopix, Llc Compositions produced using enteric pathogens and methods of use
ATE497782T1 (de) * 2004-04-16 2011-02-15 Univ Alberta Anti-gluten-eigelb-antikörper zur behanldung von zoeliakie
EP1915395A2 (en) * 2005-07-25 2008-04-30 Avianax, Inc. Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
US8877187B2 (en) * 2005-07-25 2014-11-04 Avianax, Llc Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
US20070264264A1 (en) * 2005-08-30 2007-11-15 La Belle Associates, Inc. Method and composition for conferring immunity in mammals
CA2521156A1 (en) * 2005-09-16 2007-03-16 John Hare Antibodies as growth promoting agents
EP1790358A1 (en) * 2005-11-23 2007-05-30 Université de Reims Champagne-Ardennes Protein constructs designed for targeting and lysis of cells
EP2368569A3 (en) 2006-01-18 2012-05-02 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
JP4753808B2 (ja) * 2006-06-20 2011-08-24 アサマ化成株式会社 感染症予防食品添加用組成物
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
US8282928B2 (en) * 2007-05-30 2012-10-09 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
HRP20161583T1 (hr) 2007-07-09 2016-12-30 Nestec S.A. Postupak slabljenja alergija uzrokovanih alergenima iz okoliša
CA2697538C (en) 2007-08-31 2019-02-12 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US20110166328A1 (en) * 2008-09-02 2011-07-07 Huan Nguyen Avian Antibodies Specific to Influenza Virus and Technologically Simple Methods of Their Manufacture and Use
US20110262477A1 (en) 2008-10-06 2011-10-27 University Of Chicago Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA Proteins
WO2011127032A1 (en) 2010-04-05 2011-10-13 University Of Chicago Compositions and methods related to protein a (spa) antibodies as an enhancer of immune response
SI3281947T1 (sl) 2009-04-03 2020-07-31 The University Of Chicago Sestave in metode v zvezi z variantami proteina A (SPA)
AU2010243205B2 (en) 2009-04-27 2014-09-11 Hadasit Medical Research Services & Development Limited Anti-LPS enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
US10266585B2 (en) 2009-08-28 2019-04-23 The Board Of Regents Of The Univerity Of Texas System Methods of treating brain injury
EP2566521A4 (en) * 2010-05-07 2013-11-27 Camas Inc IMMUNOGEN HINGE AND METHOD FOR THEIR MANUFACTURE AND USE
US8821894B2 (en) 2010-07-02 2014-09-02 The University Of Chicago Compositions and methods related to protein A (SpA) variants
US9943597B2 (en) 2010-08-17 2018-04-17 Immuron Limited Anti-LPS enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
US9095540B2 (en) 2010-09-09 2015-08-04 The University Of Chicago Methods and compositions involving protective staphylococcal antigens
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
MX340019B (es) * 2010-11-23 2016-06-22 Pantheryx Inc Composiciones y metodos para el tratamiento en aplicaciones clinicas de amplio espectro, no diferenciadas o combinadas.
DE102011006781A1 (de) * 2011-04-05 2012-10-11 Mat-Malta Advanced Technologies Limited Antikörperprodukt, umfassend n spezifische Antikörper
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
EP2744517B1 (en) 2011-08-15 2019-03-13 The University of Chicago Compositions and methods related to antibodies to staphylococcal protein a
BR112014026861A2 (pt) 2012-04-26 2018-05-15 Univ Chicago antígenos de estafilococos coagulase e métodos de seu uso
EP2841101B1 (en) 2012-04-26 2019-08-07 University Of Chicago Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
WO2014116721A1 (en) 2013-01-22 2014-07-31 The Arizona Board Of Regents For And On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
CA2909636C (en) 2013-04-19 2023-08-22 Dena Lyras Methods and compositions for the treatment and/or prophylaxis of clostridium difficile associated disease
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
WO2017173398A1 (en) 2016-04-01 2017-10-05 Duke University Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
US11413336B2 (en) 2018-03-23 2022-08-16 Board Of Regents, The University Of Texas System Coccidioides antigens and methods of their use
US11339387B2 (en) 2018-05-22 2022-05-24 The Government Of The United States Of America As Represented By The Secretary Of Homeland Security Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide
US12263192B2 (en) 2019-02-26 2025-04-01 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract
US11701423B2 (en) 2021-03-12 2023-07-18 Lay Sciences, Inc. Hyperimmunized egg product for treatment or prevention of coronavirus infection
JP2024518188A (ja) 2021-05-17 2024-04-26 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 抗Ｆｅｌ Ｄ１分子と動物消化物とを含むキャットフード栄養補助食品
WO2023212604A1 (en) 2022-04-27 2023-11-02 Lay Sciences, Inc. Targeted anti-sglt1 avian igy antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes
WO2023220243A1 (en) 2022-05-13 2023-11-16 Prodigy Biotech, Inc. Formulations for oral delivery of polypeptides, antibodies and proteins and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
US3646193A (en) * 1969-07-25 1972-02-29 Joseph B Michaelson Iga antibody from lacteal fluids
CH590064A5 (en, 2012) * 1973-11-28 1977-07-29 Biokema Sa
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
US4585651A (en) * 1978-10-17 1986-04-29 Stolle Research & Development Corporation Active/passive immunization of the internal female reproductive organs
GB2057451B (en) * 1979-09-05 1983-05-05 South African Inventions Immunological preparations comprising egg yolk antibodies
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit

Also Published As

Publication number Publication date
IE850289L (en) 1985-08-07
EP0152270B1 (en) 1992-09-16
JP2543633B2 (ja) 1996-10-16
DE3504221C2 (de) 1994-05-19
AU3829685A (en) 1985-08-15
JP2698778B2 (ja) 1998-01-19
DE3504221A1 (de) 1985-12-19
EP0395120A3 (en) 1990-12-19
JPS60248628A (ja) 1985-12-09
US4748018A (en) 1988-05-31
ATE135016T1 (de) 1996-03-15
CA1275044A (en) 1990-10-09
IL74155A0 (en) 1985-04-30
DK53485D0 (da) 1985-02-06
IE64365B1 (en) 1995-07-26
AU583808B2 (en) 1989-05-11
NZ211030A (en) 1989-11-28
JPH08231427A (ja) 1996-09-10
EP0152270A3 (en) 1988-01-27
HK1000183A1 (en) 1998-01-23
JPH04352729A (ja) 1992-12-07
DK227190A (da) 1990-09-20
CA1276884C (en) 1990-11-27
DK166905B1 (da) 1993-08-02
JP2698779B2 (ja) 1998-01-19
JP2690476B2 (ja) 1997-12-10
DK227190D0 (da) 1990-09-20
JPH08231426A (ja) 1996-09-10
JP2723870B2 (ja) 1998-03-09
JP2548115B2 (ja) 1996-10-30
CA1276883C (en) 1990-11-27
EP0152270A2 (en) 1985-08-21
EP0395120B1 (en) 1996-03-06
JPH08231425A (ja) 1996-09-10
DK53485A (da) 1985-08-08
JPH08231424A (ja) 1996-09-10
GR850323B (en, 2012) 1985-06-06
EP0395120A2 (en) 1990-10-31

Similar Documents

Publication Publication Date Title
IL74155A (en) Passive heterologous immunization composition containing a protein antibody derived from domesticated fowl or bovids
FI93310B (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
IT8319234A0 (it) Procedimento per la produzione di anticorpi monoclonali umani.
EP0413763A4 (en) Method for the production of monoclonal antibodies utilizing a germfree animal
DE3684211D1 (en, 2012)
DE3666529D1 (en) Canine parvovirus vaccines
ZA846191B (en) Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp
IE832452L (en) Lymphocyte growth factor
Sarnesto et al. Relative immunogenicity in mice of different regions of the human IgG
EP0381427B1 (en) Vaccine Composition
Ikehara et al. Comparative studies on muscle aldolases purified from rat, rabbit, human, pigeon, and hen
FR2571146B1 (fr) Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
EP0155172A3 (en) Anti-human lung cancer monoclonal antibodies
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
SE7901565L (sv) Medel for immunisering
KR101844829B1 (ko) 가짜 벌꿀 구별용 단클론 항체 및 이를 이용한 벌꿀 구별 방법 및 그 조성물
KR101870695B1 (ko) 벌꿀 구별용 단클론 항체 및 이를 이용한 벌꿀 구별 방법 및 그 조성물
JPH03280894A (ja) 合成糖脂質特異性モノクローナル抗体
Bergmeier et al. Separation and characterization of a 14,000-dalton cyanogen bromide-generated peptide from a 185,000-dalton streptococcal antigen
ATE59860T1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
ZHANG Preparation of monoclonal antibodies against SARS coronavirus nucleocapsid protein and preliminary analysis of antigenic epitopes
IT8322625A0 (it) Metodo per migliorare lapreparazione di prodotti di combustibili nucleari.
PL245361A1 (en) Method of obtaining antibodies specific for antigens isolated from human serum,in particular for the antigen hbs.
MX9709579A (es) Composiciones de inhibina y metodos para mejorar el rendimiento de produccion.

Legal Events

Date Code Title Description
RH Patent void